During a contentious hearing, lawmakers challenge the HHS Secretary on rising measles cases and proposed budget cuts.
Category: Politics
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. faced a barrage of tough questions during his testimony before the House Ways and Means Committee on Thursday, as lawmakers examined his record on public health and the Trump administration’s proposed budget cuts. The hearing highlighted a 675% increase in measles cases since Kennedy's appointment in February 2025, raising serious concerns about his leadership in combating vaccine misinformation and protecting vulnerable populations.
During the House Ways and Means Committee hearing, Kennedy was questioned about the Trump administration’s proposed 12.5% cut to the HHS budget for fiscal year 2027, which would reduce funding by $15.8 billion to $111.1 billion. This budget includes a staggering $923 million reduction for HIV programs, $561 million for maternal and child health, and $576 million for mental health services. In addition, the budget calls for eliminating $4.3 billion from the U.S. government’s global health budget, which is managed by the State Department.
Representative Linda Sanchez (D-CA) directly confronted Kennedy about the alarming rise in measles cases during his tenure, stating, "In 2024, under the Biden administration, there were 258 cases of measles. And in 2025, under your leadership at HHS, this ballooned to over 2,000 cases. That’s a 675% increase." She pointed out that there have already been over 1,600 confirmed cases in just the first three and a half months of 2026, indicating a concerning trend that could worsen without effective intervention.
The implications of Kennedy's testimony are far-reaching, particularly for marginalized communities. Sanchez emphasized the impact of vaccine misinformation and the administration’s actions on public health, citing the death of a six-year-old unvaccinated girl from measles as a tragic example. "A measles vaccine could have saved her life," Sanchez stated, pressing Kennedy on whether he acknowledged the role of vaccines in preventing such deaths.
In addition, the proposed cuts to maternal and child health programs disproportionately affect Black women, who are nearly three times more likely to die from pregnancy-related causes than white women. Representative Danny Davis (D-IL) criticized the Trump administration for slashing over $1 trillion from Medicaid, which funds 40% of births, and for cutting maternal health funding by over $800 million. He argued that these cuts undermine efforts to improve Black maternal health, stating, "How can we lower Black maternal health experiences if we’re cutting funds for these programs?" This sentiment reflects broader issues of health equity and the urgent need for targeted interventions.
The political fallout from Kennedy's testimony highlights a growing schism within the Republican Party, particularly around health care and public health messaging. As lawmakers from both parties expressed their discontent with the administration's approach, Kennedy attempted to deflect criticism by claiming that there had been "tremendous duplication" in programs and asserting that the administration is investing significantly in maternal health. Yet, such claims fall flat in the face of stark evidence presented by his critics.
Representative Mike Thompson (D-CA) accused Kennedy of enabling a resurgence of preventable diseases, saying, "Kids have died because measles is running rampant under your watch, in large part because President Trump allowed your conspiracy theories to run our public health." This statement captures the tension between public health officials and the administration's messaging, raising questions about accountability and the consequences of undermining established health guidelines.
As the hearing continues to echo through political circles, several key developments are on the horizon. First, expect more scrutiny on the proposed budget cuts, particularly as they relate to public health programs that serve low-income Americans. Lawmakers are likely to push back against these cuts, especially in light of the rising health crises exacerbated by the pandemic.
Second, watch for Kennedy's forthcoming testimonies before other congressional panels, where he may face even tougher questioning about his public health policies and the administration’s stance on vaccines. The response to his handling of the measles crisis and his comments on Black maternal health will be closely monitored by both supporters and critics.
Finally, the political ramifications of Kennedy’s leadership at HHS could play a role in the upcoming elections, particularly as constituents become increasingly aware of the administration's health policies and their impacts on vulnerable communities. With the midterms approaching, how Republicans and Democrats navigate these issues will be telling of their priorities and commitment to public health.